Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Aurinia Pharmaceuticals
Biotech
Aurinia pays $7M for 2 preclinical assets after January FDA nod
Aurinia Pharmaceuticals has picked up two preclinical assets for about $7 million upfront for certain autoimmune and kidney-related diseases.
Kyle LaHucik
Aug 17, 2021 11:56am
The top 10 R&D programs laid to rest in 2020
Dec 14, 2020 3:00am
Aurinia ditches would-be Restasis rival after phase 2/3 fail
Nov 2, 2020 5:05pm
Aurinia soars as phase 3 lupus study hits primary endpoint
Dec 5, 2019 7:30am
